DNA and Gene Cloning Services Market Report 2026

The dna and gene cloning services market size has grown rapidly in recent years. It will grow from $3.06 billion in 2025 to $3.48 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to academic research growth, early recombinant dna applications, limited in-house cloning capacity, pharmaceutical r&d expansion, biotechnology funding.

The dna and gene cloning services market size is expected to see rapid growth in the next few years. It will grow to $5.79 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to synthetic biology adoption, precision medicine research, biologics development growth, automation in molecular labs, global biotech investment. Major trends in the forecast period include growing demand for custom gene cloning services, increased use in drug discovery and development, expansion of synthetic and complex gene cloning, rising outsourcing by research institutions, adoption of high-throughput cloning technologies.

The increasing adoption of gene therapy is expected to drive the growth of the DNA and gene cloning services market in the coming years. Gene therapy is a treatment approach that involves modifying, replacing, or introducing genes to prevent or treat diseases. Its growing adoption is fueled by advances in biotechnology, expanding clinical success in addressing previously untreatable genetic disorders, and rising awareness among healthcare providers and patients. The DNA and gene cloning services market supports this trend by enabling precise genetic modifications, vector design, and the development of engineered constructs required for effective gene therapy products. For example, in April 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit scientific organization, reported a 10% increase in phase III gene therapy clinical trials in Q4 2023, marking the first quarterly growth since Q3 2022. Consequently, the rise in gene therapy is contributing to the growth of the DNA and gene cloning services market.

Companies operating in the DNA and gene cloning services market are increasingly focusing on advanced technologies such as artificial intelligence (AI)-driven gene editors to improve editing precision, shorten development timelines, and streamline customized genetic modification workflows for both research and therapeutic applications. AI-generated gene editors are systems designed or optimized using artificial intelligence models to create highly precise CRISPR-like proteins capable of targeting and modifying genetic sequences with greater efficiency and flexibility. For instance, in April 2024, Profluent, a US-based biotechnology research company, introduced OpenCRISPR-1, an AI-designed gene editor that enables precise genome editing through customizable CRISPR-like proteins developed using large language models, significantly expanding CRISPR capabilities and representing a major advancement in next-generation genetic engineering.

In March 2025, Integrated DNA Technologies (IDT), a US-based provider of DNA synthesis and gene cloning services, partnered with Elegen Corporation to offer early access to ENFINIA Plasmid DNA. Through this collaboration, IDT and Elegen aim to combine their respective DNA synthesis technologies by integrating IDT’s large-scale gene synthesis expertise with Elegen’s cell-free plasmid DNA manufacturing platform. This partnership is designed to deliver high-fidelity, long DNA constructs to researchers and biotechnology companies, thereby accelerating progress in synthetic biology and gene therapy applications. Elegen Corporation is a US-based biotechnology company specializing in next-generation, cell-free DNA manufacturing solutions.

Major companies operating in the dna and gene cloning services market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eurofins Scientific, Agilent Technologies Inc., Lonza Group, Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne, Curia Global Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Syngene International Limited, Twist Bioscience, New England Biolabs Inc., Origene Technologies Inc., MedGenome, Sino Biological, Genewiz Inc., Creative Biogene, Addgene.

North America was the largest region in the DNA and gene cloning services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene cloning services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dna and gene cloning services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs affect the dna and gene cloning services market by increasing costs of imported reagents, plasmid vectors, and laboratory instruments. North America and Europe are most impacted due to reliance on specialized imports, while Asia-Pacific faces higher service costs. These tariffs raise project expenses. However, they encourage domestic reagent production and regional biotech service capabilities.

The dna and gene cloning services market research report is one of a series of new reports that provides dna and gene cloning services market statistics, including dna and gene cloning services industry global market size, regional shares, competitors with a dna and gene cloning services market share, detailed dna and gene cloning services market segments, market trends and opportunities, and any further data you may need to thrive in the dna and gene cloning services industry. This dna and gene cloning services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Deoxyribonucleic acid (DNA) and gene cloning services involve laboratory techniques used to generate copies of specific DNA sequences or genes. These services include inserting a gene of interest into a plasmid vector, which is then introduced into a host organism, such as bacteria, to replicate and produce multiple copies of the gene. This process is fundamental to a wide range of applications in research, medicine, and biotechnology.

The main types of genes in DNA and gene cloning services include standard genes, complex genes, and other gene types. A standard gene is a well-characterized gene with a known sequence and function, commonly used as a reference or control in cloning workflows. The services provided include gene synthesis, custom cloning, subcloning, and others, which are applied in DNA sequencing, mutagenesis, and genotyping. These services support end users such as academic and research and development (R&D) institutions, pharmaceutical and biotechnology companies, and others.

The DNA and gene cloning services market includes revenues earned by entities by providing services such as vector design and cloning, library construction, quality control and validation, plasmid preparation, and mutagenesis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.